United Capital Financial Advisors LLC Acquires New Holdings in HCA Healthcare, Inc. $HCA

Key Points

• United Capital Financial Advisors acquired 5,085 HCA Healthcare shares worth approximately $1.98 million, while institutional investors collectively own 62.73% of the company.
• HCA reported quarterly EPS of $7.59, exceeding estimates, and revenue of $20.23 billion, up 8.7% year over year. The company also declared a quarterly dividend of $0.78 per share, yielding about 0.7%.
• Analysts maintain a “Moderate Buy” consensus with an average price target of $462.64, compared with the stock’s recent opening price of $417.57; ratings include 14 Buys, eight Holds and one Sell.

United Capital Financial Advisors LLC purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 5,085 shares of the company's stock, valued at approximately $1,983,000.

A number of other large investors have also recently bought and sold shares of HCA. BlackRock Inc. acquired a new position in shares of HCA Healthcare in the 2nd quarter valued at about $5,069,974,000. State Street Corp lifted its stake in HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company's stock valued at $3,532,563,000 after buying an additional 76,039 shares during the period. Capital World Investors grew its position in shares of HCA Healthcare by 0.8% during the 4th quarter. Capital World Investors now owns 4,999,422 shares of the company's stock worth $2,334,040,000 after buying an additional 40,086 shares during the period. Geode Capital Management LLC lifted its position in shares of HCA Healthcare by 0.4% during the 4th quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company's stock valued at $1,702,738,000 after acquiring an additional 13,565 shares during the period. Finally, Norges Bank acquired a new stake in HCA Healthcare in the fourth quarter worth $1,262,513,000. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $417.57 on Friday. The company has a market capitalization of $90.40 billion, a price-to-earnings ratio of 13.98, a PEG ratio of 1.46 and a beta of 1.10. The company has a 50-day simple moving average of $401.08 and a two-hundred day simple moving average of $441.46. HCA Healthcare, Inc. has a 52-week low of $353.99 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts' consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare's revenue was up 8.7% on a year-over-year basis. During the same period last year, the business posted $6.84 earnings per share. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 29.42 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Wednesday, September 16th. HCA Healthcare's payout ratio is presently 10.45%.

Wall Street Analysts Forecast Growth

HCA has been the subject of several research reports. Morgan Stanley reduced their target price on HCA Healthcare from $425.00 to $380.00 and set an "underweight" rating for the company in a research note on Monday, July 27th. TD Cowen reduced their price objective on HCA Healthcare from $500.00 to $431.00 and set a "buy" rating for the company in a research note on Monday, June 22nd. Royal Bank Of Canada reiterated an "outperform" rating and issued a $435.00 target price on shares of HCA Healthcare in a report on Monday, July 27th. Mizuho decreased their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an "outperform" rating for the company in a research note on Tuesday, July 28th. Finally, Deutsche Bank Aktiengesellschaft set a $476.00 price objective on shares of HCA Healthcare in a report on Monday, July 27th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $462.64.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source